comparemela.com

Latest Breaking News On - Vanda pharmaceuticals price performance - Page 1 : comparemela.com

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 16.9% in April

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 2,070,000 shares, a decline of 16.9% from the March 31st total of 2,490,000 shares. Based on an average trading volume of 2,290,000 shares, the days-to-cover ratio is presently 0.9 […]

Switzerland
China
Ohio
United-states
Swiss
Swiss-national-bank
China-universal-asset-management-co
Vanda-pharmaceuticals
Nasdaq
Vanda-pharmaceuticals-price-performance
News-ratings-for-vanda-pharmaceuticals-daily

Vanda Pharmaceuticals (NASDAQ:VNDA) Downgraded by StockNews.com to Hold

StockNews.com downgraded shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) from a buy rating to a hold rating in a report issued on Monday. Separately, TheStreet lowered Vanda Pharmaceuticals from a c- rating to a d rating in a research note on Thursday, February 8th. View Our Latest Analysis on VNDA Vanda Pharmaceuticals Price Performance […]

China
New-york
United-states
Switzerland
Swiss
Nasdaq
Vanda-pharmaceuticals-price-performance
News-ratings-for-vanda-pharmaceuticals-daily
Institutional-investors-weigh-in-on-vanda-pharmaceuticals
China-universal-asset-management-co
Vanda-pharmaceuticals-inc

Vanda Pharmaceuticals (NASDAQ:VNDA) Cut to Hold at StockNews.com

Vanda Pharmaceuticals (NASDAQ:VNDA) Cut to Hold at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Capital-partners
Vanda-pharmaceuticals-inc
Nasdaq
Vanda-pharmaceuticals-price-performance
News-ratings-for-vanda-pharmaceuticals-daily
Stonepine-capital-management
Vanda-pharmaceuticals-company-profile
Acadian-asset-management
Exchange-traded-concepts
Vanda-pharmaceuticals
Institutional-trading-of-vanda-pharmaceuticals

Profit Investment Management LLC Cuts Stock Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Profit Investment Management LLC lessened its holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 1.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 328,668 shares of the biopharmaceutical company’s stock after selling 4,195 shares during the period. Vanda Pharmaceuticals […]

Stephen-ray-mitchell
Panagora-asset-management-inc
Yousif-capital-management
Commonwealth-of-pennsylvania-public-school-empls-retrmt
Securities-exchange-commission
Vanda-pharmaceuticals-inc
Vanda-pharmaceuticals-price-performance
Exchange-commission
Metlife-investment-management
News-ratings-for-vanda-pharmaceuticals-daily
Jpmorgan-chase-co
Quarter-for-vanda-pharmaceuticals

vimarsana © 2020. All Rights Reserved.